Home > Shop > Dihexa
Home > Shop > Dihexa

Dihexa

Price range: €43.00 through €79.00

Dihexa, or N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, first known PNB-0408, is a novel nootropic compound and experimental drug that has been developed for possible treatment of trauma-based brain disorders and neurodegenerative conditions (i.e., Alzheimer’s, Parkinson’s) that would compensate for arisen cognitive deficits through increased synaptogenesis.

It is an oligopeptide (small peptide) drug derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF), a neurotrophic agent in many brain regions, and potentiates its activity at its receptor, c-Met.

Studies in rats have shown its enormous potency as a neurotrophic agent, being up to ten million times stronger than BDNF (brain-derived neurotrophic factor). Furthermore, dihexa possess neuroprotective properties, as other animal studies have demonstrated anti-inflammatory and anti-apoptotic effects of the drug.

Since this substance hasn’t been tested in humans, caution is advised when handling this extremely potent nootropic.

SKU: dihexa Category:
SKU

dihexa

ACTIVE INGREDIENT:

Dihexa

ADDITIONAL INGREDIENTS:

–

OTHER NAMES:

N-(1-Oxohexyl)-l-tyrosyl-N-(6-amino-6-oxohexyl)-l-isoleucinamide

CAS NUMBER:

1401708-83-5

ATC CODE:

–

FORMULA:

C27H44N4O5

MOLAR MASS:

504.672 g·mol−1

ITEM TYPE:

powder

QUANTITY PER PACK:

0.250 gram and 0.5 gram

STORAGE:

Store in a cool and dry place (Dihexa is hygroscopic). Keep away from direct sunlight and heat. Keep out of reach of children.

SCOOPS:

This product includes a measuring scoop (0.025 ml) = 5 mg (approximately).

Description

Dihexa

SKU: dihexa

For precise measurement, we recommend using a laboratory scale.

The product is not intended for human use. For collectors, hobbyists, education and research.

Dihexa, or N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, first known PNB-0408, is a novel nootropic compound and experimental drug that has been developed for possible treatment of trauma-based brain disorders and neurodegenerative conditions (i.e., Alzheimer’s, Parkinson’s) that would compensate for arisen cognitive deficits through increased synaptogenesis.

It is an oligopeptide (small peptide) drug derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF), a neurotrophic agent in many brain regions, and potentiates its activity at its receptor, c-Met.

Studies in rats have shown its enormous potency as a neurotrophic agent, being up to ten million times stronger than BDNF (brain-derived neurotrophic factor). Furthermore, dihexa possess neuroprotective properties, as other animal studies have demonstrated anti-inflammatory and anti-apoptotic effects of the drug.

Since this substance hasn’t been tested in humans, caution is advised when handling this extremely potent nootropic.

Additional information

Weight

,